A Study of AZD8233 in Participants with Dyslipidemia

Trial Identifier: D7990C00003
Sponsor: AstraZeneca
NCTID:: NCT04641299
Start Date: October 2020
Primary Completion Date: July 2021
Study Completion Date: July 2021
Condition: Heart, Blood & Circulatory - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English version
Danish Translation
Slovak Translation
Spanish Translation

Trial Locations

Country Location
Canada, NB Moncton, NB, Canada, E1G 1A7
Canada, ON Toronto, ON, Canada, M9W 4L6
Canada, ON Toronto, ON, Canada, M4G 3E8
Canada, QC Chicoutimi, QC, Canada, G7H 7K9
Canada, QC Saint-Marc-des-Carrieres, QC, Canada, G0A 4B0
Denmark Aarhus N, Denmark, 8200
Denmark Frederiksberg, Denmark, 2000
Denmark Herlev, Denmark, 2730
Denmark Roskilde, Denmark, 4000
Denmark Viborg, Denmark, 8800
Slovakia Bratislava, Slovakia, 831 03
Slovakia Bratislava, Slovakia, 85101
Slovakia Rožňava, Slovakia, 048 01
Slovakia Trebišov, Slovakia, 7501
United States of America, CA Roseville, CA, United States of America, 95661
United States of America, FL Inverness, FL, United States of America, 34452
United States of America, FL Jacksonville, FL, United States of America, 32216
United States of America, FL Pembroke Pines, FL, United States of America, 33024
United States of America, ID Meridian, ID, United States of America, 83646
United States of America, IN Indianapolis, IN, United States of America, 46260
United States of America, NC Greensboro, NC, United States of America, 27408
United States of America, ND Fargo, ND, United States of America, 58104
United States of America, NY New Windsor, NY, United States of America, 12553
United States of America, OH Cincinnati, OH, United States of America, 45219
United States of America, SC Mount Pleasant, SC, United States of America, 29464